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Longitudinal study of Middle East Respiratory
Syndrome coronavirus infection in dromedary camel
herds in Saudi Arabia, 2014–2015
Maged Gomaa Hemida1,2,*, Abdulmohsen Alnaeem3,*, Daniel KW Chu4,*, Ranawaka APM Perera4,*,
Samuel MS Chan4, Faisal Almathen5, Emily Yau4, Brian CY Ng4, Richard J Webby6, Leo LM Poon4
and Malik Peiris4
Two herds of dromedary camels were longitudinally sampled with nasal and rectal swabs and serum, between September 2014
and May 2015, and the samples were tested for Middle East Respiratory Syndrome (MERS) coronavirus RNA and antibodies.
Evidence of MERS-CoV infection was conﬁrmed in one herd on the basis of detection of virus RNA in nasal swabs from three
camels and signiﬁcant increases in the antibody titers from three others. The three viruses were genetically identical, thus
indicating introduction of a single virus into this herd. There was evidence of reinfection of camels that were previously
seropositive, thus suggesting that prior infection does not provide complete immunity from reinfection, a ﬁnding that is relevant
to camel vaccination strategies as a means to prevent zoonotic transmission.
Emerging Microbes & Infections (2017) 6, e56; doi:10.1038/emi.2017.44; published online 21 June 2017
Keywords: camel; cohort; coronavirus; dromedary; immunity; MERS coronavirus; reinfection
INTRODUCTION
Middle East Respiratory Syndrome coronavirus (MERS-CoV) was
initially identiﬁed in Saudi Arabia in 2012.1 As of 5 December 2016,
there were over 1800 laboratory-conﬁrmed cases.2 Camels are known
to be the natural host for MERS-CoV and the source of zoonotic
infection.3–5 Zoonotic transmission events may be mild and unrecog-
nized but may lead to transmission between humans, thus leading to
MERS outbreaks in health care facilities.6,7 The SARS epidemic of
2003 was heralded by repeated small zoonotic outbreaks in 2002 that
were self-limited until a strain of SARS CoV that was well adapted to
humans emerged and led to a global epidemic that affected approxi-
mately 8000 patients in 25 countries across ﬁve continents.8 Given this
demonstration of the capacity for novel coronaviruses to emerge from
animals to cause major outbreaks in humans, the threat from MERS-
CoV remains a cause for global health concern.
Vaccination of dromedary camels has been proposed as a means to
reduce the threat of zoonotic MERS.9 It is therefore important to
establish the epidemiology of MERS-CoV transmission within camels,
and especially whether prior infection protects against subsequent
reinfection. We therefore carried out a longitudinal study of two camel
herds in the Kingdom of Saudi Arabia to elucidate MERS-CoV
infection and transmission.
MATERIALS AND METHODS
Sample collection
Nasal and rectal swabs and serum samples were collected from
dromedary camels in two herds in the Eastern and Central regions
of Saudi Arabia between September 2014 and May 2015. The same
animals were resampled whenever possible. The ages of the animals
were assessed on the basis of farm records and, when records were not
available, by examination of dentation. Swab samples were collected in
viral transport medium and stored at − 80 °C.
Herd 1. This group was a closed camel herd of ~ 80 animals in the
Eastern Province. The camels were housed in one compound and
provided with feed in barns. There was no contact with nomadic
camel herds. Occasionally, animals purchased from outside (for
example, camel markets) may be introduced into the herd. A previous
study of this camel herd has been published.10
Herd 2. This group was a camel herd of ~ 100 dromedaries in the
Central Province. The animals were held in one barn and were
separated into several subgroups (males, pregnant and lactating
animals). The different animal groups were separated within the same
compound by only a fence. Although this herd was largely closed,
animals purchased from local markets are occasionally introduced to
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the herd. Nomadic camel herds of Bedouins graze in the surrounding
area, especially in the fall and winter. Other animals, such as sheep and
goats, are also sometimes present in the same area. Stray dogs, foxes,
rodents and birds such as doves and crows are also frequently seen in
proximity to this herd.
RT-PCR and serology testing
The total nucleic acid extracted from the swabs was tested for
MERS-CoV RNA by using reverse transcription PCR (RT-PCR).
An RT-PCR assay targeting the region upstream of the envelope
protein gene (upE) was used for screening, and the conﬁrmation of
any screen-positive samples was done using RT-PCR that targeted
open reading frame 1a (ORF-1a).4,11 A 7675 nucleotide (nt) region of
the genome from the spike gene to the N gene (22 140–29 814 nt in
the reference MERS-EMC strain sequence) was RT-PCR ampliﬁed as
overlapping PCR amplicons and sequenced by Sanger sequencing
from any RT-PCR-positive samples.
Evidence of other coronaviruses was sought by testing the swab
samples using a pan-coronavirus-nested PCR that was targeted at the
conserved RNA-dependent RNA polymerase (RdRp) gene of corona-
viruses that we have previously developed and reported.4,12
MERS-CoV antibody was tested using a validated MERS-CoV spike
pseudoparticle neutralization test (ppNT) as previously described.13
RESULTS
In herd 1, 29 camels, including 2 calves, were sampled; 8 were sampled
in October 2014, 9 in November 2014, 15 in January 2015 and 13 in
February 2015. Animals had both swabs and serum collected, with the
exception of one animal in November, one in January and one in
February. The MERS-CoV RNA was not detected in any of the camels
sampled from herd 1 (Table 1). All the camels that were sampled had
MERS-CoV antibody, thus indicating past infection.
In herd 2, 70 dromedaries were sampled, including 16 calves ⩽ 2
years of age, 5 animals 3–5 years of age, 35 animals ⩾ 6 years of age
and 14 animals of undetermined age. Ten camels were sampled
in September 2014, 43 in October 2014, 28 in November 2014, 45 in
January 2015, 24 in February/March 2015 and 52 in May 2015.
The number of swabs and sera collected at each sampling occasion is
detailed in Table 2. The results are summarized in Table 3. Both nasal
and rectal swabs were collected, except where indicated in Table 2.
MERS-RNA was detected in nasal swabs from three dromedaries in
November 2014 (Tables 2 and 3), thus suggesting that this herd was
infected with MERS-CoV. The corresponding rectal swabs were
RT-PCR negative. The viral load in these three nasal swab specimens
was 2.2 × 103 copies per mL (specimen F2-3); 0.7 × 103 copies per mL
(specimen F2-33) and 1.4 × 103 copies per mL (specimen F2-51)
(Table 4). These three animals were seropositive in the sampling
carried out in November and did not demonstrate fourfold increases
in their antibody titers after infection (Tables 2 and 4). None of the
rectal swabs were positive for MERS-CoV. MERS-CoV antibody titers
in animals with sequential serum samples showed three other animals
with signiﬁcant (fourfold or greater) increases in antibody titers, thus
suggesting MERS-CoV infection in three additional animals in the
periods September–October 2014 (animal F2-26),
November 2014–January 2015 (animal F2-34) and March–May 2015
(animal F2-5) (Tables 2 and 4). These results suggested that virus
transmission occurred during the September–October 2014 period
and continued through to March–May 2015.
A 7675 nt region of the genome from the spike gene to the N gene
was sequenced from the three positive samples (GenBank accession
numbers KY706245–KY706247). These three sets of sequences were
found to be identical to each other, thus suggesting that a single
virus had been introduced into this herd. The sequences were
closely related but not genetically identical to the MERS-CoV strain
Riyadh/Riyadh179/2015 (GenBank accession no.: KT368875), which
has been previously reported in dromedaries in Saudi Arabia
(Figure 1). In addition, a 1164 nt region of the N gene
(28 650–29 814 nt of MERS-CoV genome) was sequenced from these
three viruses and were found to be identical to each other. Phylogeny
also conﬁrmed that these viruses were identical and closely related to
Riyadh/Riyadh179/2015 (data not shown).
Pan-coronavirus RT-PCR detecting most known (and likely
unknown) coronaviruses was negative.
DISCUSSION
Our longitudinal study on two dromedary herds demonstrated high
levels of seropositivity in both herds, a result in agreement with
ﬁndings from many other studies reporting high seroprevalence in
adult animals in the Arabian Peninsula and Africa.3,4,13–17 One of these
herds, namely, herd 2, had evidence of an active MERS-CoV infection.
The RT-PCR detection of MERS-CoV conﬁrmed the infection of three
camels in November 2014, and viral molecular epidemiology
conﬁrmed that these three infections most probably arose from
introduction of one virus into the herd. The three animals that were
RT-PCR positive for MERS-CoV in November 2014 were seropositive
in the previous serum sampling in October but were reinfected in spite
of prior moderate (titer 1:320) or high (1:40 960) antibody titers.
Because these animals were 2 years of age, the serum antibody that was
detected prior to infection would have resulted from infection after
birth rather than being antibody passively acquired from the dam.
Given the camels’ age, such natural infections had occurred within the
past 2 years.
Table 1 Dromedary herd 1: specimens collected and MERS-CoV RT-PCR and screening antibody test results
October 2014 November 2014 January 2015 February 2015
RT-PCR positive
Antibody
positivea RT-PCR positive
Antibody
positive RT-PCR positive
Antibody
positive RT-PCR positive
Antibody
positive
No. of
animals tested
8 8 9 8 15 15 13 12
Sex F=7; M=1 F=7; M=2 F=11; M=4 F=10; M=3
Age (years) 2, 5, 9, 9, 10,
11, 13, 14
0.7,0.8, 0.8, 3, 4,
4, 4, 8, 8
0.3, 0.5, 1.5, 3, 3, 4, 4, 4, 5, 6,
8, 10, 12, 13, 14
1, 3, 3, 4, 4, 4, 4, 5, 6,
10, 12, 13, 13
No. of positive 0 8 0 8 0 14 0 12
% Positive 0 100 0 100 0 100 0 100
aMERS-CoV antibody positive at a screening dilution of 1:20.
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A previous study of another infected camel herd has shown
infection of both adults and calves.10 Because adult animals (which
are very likely to be seropositive) and a 2-week-old calf (which was
very likely to have maternal antibodies) were found to be infected, it
was presumed that neither prior natural infection nor passive
antibodies would produce sterilizing immunity.10 However, there
was no conclusive evidence of antibody detected prior to infection.
The lack of correlation between the viral RNA loads and the levels of
neutralizing antibody in camels slaughtered in an abattoir in Qatar has
also been taken to indicate that prior antibodies may not provide
sterilizing immunity.17 However, again, conclusive evidence of the
presence of antibodies before infection was not available. In contrast, a
study of infection within camel herds whose dam and calf pairs were
studied, has reported that infection occurred in the calves but not in
the seropositive dams, thus suggesting that prior immunity in older
animals may prevent reinfection.16 In another study in which 11 calves
were prospectively followed up during the ﬁrst year of life, ﬁve calves
were found to be infected within the ﬁrst month of life even though
they had evidence of passively acquired maternal antibodies, thus
suggesting that the maternal antibodies do not provide complete
protection from reinfection.18 Evidence of reinfection of adult
seropositive camels was also reported in a longitudinal study of camels
in Egypt.19
The present study provides conclusive evidence that reinfection of
previously seropositive camels can occur. This observation has
important implications for the feasibility of using vaccination of
camels as a means to control MERS-CoV transmission within camel
herds with the aim of reducing zoonotic transmission. Reinfection in
previously seropositive animals may occur because MERS-CoV
infection in camels is a mucosal infection and the serum antibody
might not be an accurate predictor of the effective mucosal antiviral
immunities that can provide sterilizing immunity. None of the studies
to date, including our own, have tested for evidence of mucosal IgA
immunity in the oral or nasopharyngeal cavity, and this deﬁciency
remains a crucial gap in the understanding of protection from
reinfection.
The lack of protection against natural reinfection in the ﬁeld thus
raises questions about the potential duration of protection conferred
by MERS-CoV infection or vaccines. Previous experimental studies of
camels vaccinated with a vaccinia-vectored MERS-CoV vaccine that
were challenged 3 weeks later with a dose of 107 TCID50 MERS-CoV
inoculated intra-nasally showed a decrease, but not a complete
elimination of detectable virus RNA or infectious virus.9 However,
this test was an experimental challenge with what may be a
non-physiological dose of virus and after a very short
post-vaccination interval. These conditions may not reﬂect the
situation in the ﬁeld. Experimentally infected alpacas have been found
to be protected against MERS-CoV reinfection; again, this study
involved a challenge that occurred at a short interval after the previous
infection.20
In contrast to data from the experimental challenge of vaccinating
animals, our studies have merit in that the infecting dose leading to
infection was physiologically relevant to the ﬁeld conditions and that
the challenge probably occurred many months or years after the initial
infection. The viral load in nasal swabs in the three RT-PCR-positive
specimens was low and ranged from 0.7× 103 to 2.2× 103 copies per
mL. In contrast, the viral loads in camels in our previously reported
study of transmission within a camel herd ranged from 3.3× 103 to
1.78× 108 copies per mL. It is not clear whether the low viral load
observed in the reinfected animals in herd 2 would be sufﬁcient to
result in onward transmission to other animals.Ta
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In addition to the three RT-PCR-positive camels, the serology data
conﬁrmed evidence of infection in three other camels from as early as
September–October 2014 and conﬁrmed that the infection was active
until the November 2014–January 2015 period. Whether these
infections were also a result of the same virus introduction cannot
be conﬁrmed, but this possibility is likely. If this were the case, a single
introduction of MERS-CoV would probably have led to virus
circulation in herd 2 from September 2014 until at least November
2014, a period of 2–3 months. In a previous study of herd 1,
we have demonstrated virus circulation for at least 1 month,
November–December 2013.10 Data from this study showed that
camels in herd 2 that were RT-PCR positive did not demonstrate a
fourfold increase in antibody titer, although two camels showed a
non-signiﬁcant twofold increase in titers. Thus, we cannot exclude
infections in other sampled animals whose antibody titers were not
observed to rise by fourfold, the usual criterion for a signiﬁcant
antibody response. Because of these observations, and because all
animals in herd 2 were not sampled, our detection of six infected
camels is likely to be an underestimate of the extent of transmission
within this herd.
Age data were available for 56 of the sampled camels in herd 2.
Among those animals with a known age, 5 (83.3%) of the 6 camels
with evidence of MERS-CoV infection, either by RT-PCR or
serological tests, were aged 2 years or younger, whereas only 11
(22.8%) of the 50 MERS-CoV-negative animals were of similar age
(Fisher’s test P= 0.0056). This result suggested that younger camels are
more likely to acquire infection within an infected herd, as has been
previously reported.16
A limitation of the present study was that the viral load data
were available at only one point in time during the time course of
infection, because the interval between specimens was ⩾ 1 month.
Furthermore, specimens were not collected every month from all
the animals that were followed up. Information on mucosal
antibody titers would have been very useful, but it is known that
antibodies that are functional (for example, neutralizing) against
viruses are very difﬁcult to accurately assay because of the presence
of many non-antibody-mediated mechanisms for virus neutraliza-
tion in saliva.
Another limitation in our study was that our neutralization tests
were done with MERS from the EMC strain rather than a
contemporary MERS-CoV strain. However, we and others
have shown that genetically diverse MERS-CoV are antigenically
homogenous in cross-neutralization tests carried out by
conventional microneutralization or pseudotype neutralization
tests.10,21 Thus, virus antigenic variation was unlikely to confound
our serological tests or lead to antigenic escape from prior
antibody immunity.
In conclusion, we demonstrate the reinfection of camels that were
previously seropositive with very high serum antibody titers. It may be
possible that such reinfections are associated with lower viral loads and
may be less transmissible to other animals, but this hypothesis remains
to be conﬁrmed. Well-designed ﬁeld studies of vaccinated animals
Table 3 Dromedary herd 2: specimens collected and summary results of MERS-CoV RT-PCR, antibody screening and rising antibody titers
September 2014 October 2014 November 2015 January 2015 February–March 2015 May 2015
RT-
PCR
Antibody positive
or rising antibody
titersa
RT-
PCR
Antibody positive
or rising antibody
titersa
RT-
PCR
Antibody positive
or rising antibody
titersa
RT-
PCR
Antibody positive
or rising antibody
titersa
RT-
PCR
Antibody positive
or rising antibody
titersa
RT-
PCR
Antibody positive
or rising antibody
titersa
No. of
animals tested
10 8 25 34 26 26 45 43 21 24 51 44
No. of RNA
positive
0 NR 0 NR 3 NR 0 NR 0 NR 0 NR
No. of sero
positive
NR 8 NR 34 NR 26 NR 43 NR 24 NR 44
No. of rise in
antibody titers
NR NR NR 1 NR 0 NR 1 NR 0 NR 1
Abbreviation: not relevant, NR.
aMERS-CoV antibody positive at a screening dilution of 1:20; fourfold rise in antibody titer.
Table 4 Dromedary herd 2: Viral load and reciprocal antibody titers of the six animals with evidence of MERS-CoV infection
Animal ID
number
Age (years)
and sex September 2014 October 2014 November 2015 January 2015
February-March
2015 May 2015
RT-
PCR
Antibody
titers
RT-
PCR
Antibody
titers
RT-PCR positive (viral load genome
copies per mL)
Antibody
titers
RT-
PCR
Antibody
titers
RT-
PCR
Antibody
titers
RT-
PCR
Antibody
titers
F2-3 2, F NA NA NA 2560 Pos (2.2×103) 5120 NA NA NA NA NA NA
F2-33 2, M NA NA Neg 40960 Pos (0.7×103) 40960 Neg 40960 NA NA Neg 20480
F2-51 2, F NA NA Neg 320 Pos (1.4×103) 320 Neg 640 NA 320 Neg NA
F2-26 8, F Neg 320 Neg 1280 Neg 2560 NA ND Neg 1280
F2-34 2, F NA NA Neg 320 Neg 320 Neg 1280 NA NA Neg 1280
F2-5 1, F NA NA NA NA NA NA NA NA Neg 160 Neg 640
Abbreviation: specimen not available, NA.
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followed up over a period of longer than 1 year would be required to
assess the effects of vaccination on decreasing virus transmission
between camels. Longitudinal studies of dromedary herds such as
those reported here provides useful data for the design of such
systematic studies.
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